FIELD: medicine.
SUBSTANCE: invention refers to veterinary science, and aims at treating viral diseases in animals. What is declared is a composition for treating viral diseases in animals, containing two subtypes of vertebrate recombinant interferon mixed in equal molar proportions.
EFFECT: use of the declared composition enables ensuring the substantial increase of the therapeutic effect of recombinant interferons and minimising the potential adverse effects associated with their use.
4 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITIONS AND METHODS FOR POTENTIATING THERAPEUTIC EFFECTS OF INTERFERONS | 2001 |
|
RU2242243C2 |
AGENT FOR TREATMENT AND PROPHYLAXIS OF NATURAL INFECTIOUS DISEASES IN CATS | 2014 |
|
RU2576814C1 |
METHOD FOR THE TREATMENT OF SUBCLINICAL MASTITIS IN LACTATING COWS | 2022 |
|
RU2783249C1 |
BIFIDOBACTERIUM LONGUM, ABLE TO MODULATE THE IMMUNE RESPONSE TO A RESPIRATORY VIRAL INFECTION | 2018 |
|
RU2768030C2 |
RECOMBINANT INTERFERON-ALPHA DOG PREPARATION FOR USE IN THERAPY OF NATURAL VIRAL INFECTIONS OF DOGS | 2018 |
|
RU2694210C1 |
ALPHA-INTERFERON COMPOSITION AND METHOD OF PREPARATION THEREOF FROM HUMAN BLOOD LEUKOCYTES | 1993 |
|
RU2129437C1 |
IMMUNOCORRECTIVE AGENT FOR TREATING DISEASES OF VIRAL AETIOLOGY | 2007 |
|
RU2411039C2 |
VETERINARY COMPOSITION CONTAINING HUMAN RECOMBINANT INTERFERON ALPHA-2B, TOCOPHEROL ACETATE AND ASCORBIC ACID, BASED VETERINARY DRUG PREPARATION MULTIFERON AND USE OF DRUG PREPARATION MULTIFERON AS ANTIVIRAL AND IMMUNOMODULATORY AGENT IN VACCINATION SCHEDULES FOR YOUNG AGRICULTURAL ANIMALS | 2011 |
|
RU2481854C2 |
TABLETTED PHARMACEUTICAL COMPOSITION FOR TREATING SEVERE FORMS OF VIRAL INFECTIONS | 2014 |
|
RU2559179C1 |
NOVEL AVIAN CYTOKINES AND GENETIC SEQUENCES CODING THEREOF | 2008 |
|
RU2562108C2 |
Authors
Dates
2013-05-27—Published
2010-06-07—Filed